Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Histone acetyltransferase p300 is a coactivator for transcription factor REL and is C-terminally truncated in the human diffuse large B-cell lymphoma cell line RC-K8.

Cancer letters | May 28, 2010

Human c-Rel (REL) is a member of the NF-kappaB family of transcription factors. REL's normal physiological role is in the regulation of B-cell proliferation and survival. The REL gene is amplified in many human B-cell lymphomas and overexpression of REL can transform chicken lymphoid cells. In this report, histone acetyltransferase p300 enhanced REL-induced transactivation and interacted with REL both in vitro and in REL-transformed chicken spleen cells and the B-lymphoma cell line RC-K8, in which REL is constitutively active and required for proliferation. However, due to a deletion in the EP300 locus, only a C-terminally truncated form of p300 is expressed in RC-K8 cells. These results suggest a role for p300 in REL-mediated oncogenic activity in B lymphoma.

Pubmed ID: 19948376 RIS Download

Mesh terms: Animals | Cell Line, Tumor | Cell Transformation, Neoplastic | Cells, Cultured | Chickens | Genes, Reporter | Glutathione Transferase | Histone Acetyltransferases | Humans | Kidney | Luciferases | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | NF-kappa B | Polymerase Chain Reaction | Proto-Oncogene Proteins c-rel | Recombinant Fusion Proteins | Transfection

Research resources used in this publication

None found

Research tools detected in this publication

None found

Data used in this publication

None found

Associated grants

  • Agency: NCI NIH HHS, Id: R01 CA047763
  • Agency: NCI NIH HHS, Id: CA047763
  • Agency: NCI NIH HHS, Id: CA047763-21S3
  • Agency: NCI NIH HHS, Id: R01 CA047763-21S1
  • Agency: NCI NIH HHS, Id: R01 CA047763-21

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

We have not found any resources mentioned in this publication.